These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 26136371)

  • 21. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
    Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
    Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.
    Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F
    World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.
    Ueno H; Okusaka T; Ikeda M; Ishiguro Y; Morizane C; Matsubara J; Furuse J; Ishii H; Nagase M; Nakachi K
    Oncology; 2005; 69(5):421-7. PubMed ID: 16319514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer.
    Kim MK; Lee KH; Jang BI; Kim TN; Eun JR; Bae SH; Ryoo HM; Lee SA; Hyun MS
    Jpn J Clin Oncol; 2009 Jan; 39(1):49-53. PubMed ID: 19060295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection.
    Shimoda M; Kubota K; Shimizu T; Katoh M
    Br J Surg; 2015 Jun; 102(7):746-54. PubMed ID: 25833230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biweekly gemcitabine plus S-1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study.
    Wada K; Sano K; Amano H; Miura F; Toyota N; Ito H; Shibuya M; Ikeda Y; Kainuma M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):692-8. PubMed ID: 26136371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].
    Murakami Y; Uemura K; Sudo T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141
    [No Abstract]   [Full Text] [Related]  

  • 28. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials.
    Zhong S; Qie S; Yang L; Yan Q; Ge L; Wang Z
    Medicine (Baltimore); 2017 Jul; 96(30):e7611. PubMed ID: 28746215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Li D; Chen C; Zhou Y; Chen R; Fan X; Bi Z; Li Z; Liu Y
    Medicine (Baltimore); 2015 Sep; 94(35):e1345. PubMed ID: 26334891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent important insights into treatment of pancreatic cancer].
    Abe N; Sugiyama M; Atomi Y
    Gan To Kagaku Ryoho; 2005 May; 32(5):617-23. PubMed ID: 15918560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of unresectable pancreatic cancer - successful resections after gemcitabine-based chemotherapy].
    Sakuraba S; Toyoki Y; Ishido K; Kudo D; Kimura N; Wakiya T; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1878-80. PubMed ID: 24393952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pancreatic cancer showing complete pathological response to preoperative chemoradiotherapy-a case report].
    Tanizaki K; Hama N; Tomimaru Y; Eguchi H; Akita H; Wada H; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1872-4. PubMed ID: 24393950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of postoperative brain metastasis originated from pancreatic cancer which was successfully treated by resection and postoperative irradiation].
    Matsumura T; Ohzato H; Yamamoto T; Ota K; Mabuchi E; Miwa H; Ikeda H; Fukunaga M; Furukawa H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2433-5. PubMed ID: 20037447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnologies in Pancreatic Cancer Therapy.
    Manzur A; Oluwasanmi A; Moss D; Curtis A; Hoskins C
    Pharmaceutics; 2017 Sep; 9(4):. PubMed ID: 28946666
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.